SUMMARY Thirteen meningiomas of varying light microscopic features were studied immunohistologically using a panel of monoclonal antibodies directed against epithelial, mesenchymal, and neural components. All 13 meningiomas showed expression of epithelial membrane antigen, vimentin, and S100 protein, as did normal meninges. Five of the 13 meningiomas also showed focal expression of cytokeratins, with double labelling showing expression of cytokeratins and vimentin by different cells. The cytokeratin expression was especially noticeable in cells surrounding the hyaline bodies of meningiomas. These results provide further evidence that meningiomas have features of both mesenchymal and epithelial tissues.
Meningiomas are primary tumours thought to arise from the arachnoidal cap cell of the meninges.' As the meninges are believed to develop from the connective tissue surrounding the neural tube, meningiomas are considered to be mesenchymal tumours.' Meningiomas, however, show considerable heterogeneity on light microscopy' 2 and, indeed, can have epithelial features such as large numbers of desmosomes.3 Furthermore, occasional tumours contain periodic acid Schiff (PAS) positive hyaline bodies, which, ultrastructurally, can resemble the intracytoplasmic lumina of some adenocarcinomas, and which Kepes has suggested reflects secretory differentiation by meningioma cells.4
In this study a series of meningiomas of varying morphological patterns was examined with a panel of monoclonal antibodies, which recognises a variety of antigens of epithelial, mesenchymal, and neural type. The aim of this study was to clarify the origin of meningiomas, their relation to other cells and tissues, and to establish whether a panel of monoclonal antibodies might be useful in their differential diagnosis.
Material and methods
Thirteen cases of meningioma were recovered from the files of the neuropathology department, The Radcliffe Infirmary, Oxford, or the histopathology department, John Radcliffe Hospital, Oxford. All had been routinely fixed in formalin and embedded in paraffin wax. Five of the meningiomas were also positively labelled by at least one of the three anticytokeratin antibodies. This staining was restricted mainly to the cytoplasm of a minority of the tumour cells and was particularly noticeable in the cells surrounding the PAS positive hyaline bodies seen in cases 2, 3, and 4 (Fig. 4) thelial and non-epithelial antigens.
We have shown vimentin expression by normal meninges, and, in accordance with previous studies,10 11 all the meningiomas. As vimentin is the intermediate filament of mesenchymal cells this result can be interpreted as supporting the view that meningiomas are mesenchymal tumours arising from normal meningothelial cells. We also observed S1OO protein expression in arachnoidal cap cells and within meningiomas, confirming its previous detection in these tumours. 2 The importance of this is unclear, as in our experience, SI 00 protein can be detected in a wide range of tissues and tumours, and is not specific for neuroectoderm (personal observation).
A further consistent finding, however, has been the positivity of normal meninges and all the tumours for the epithelial membrane antigen (EMA), an antigen which is widely expressed in epithelial tissues.13 14 One striking observation was the relation of cytokeratin expression to hyaline bodies in some tumours (Fig. 4) . The tendency for meningothelial meningiomas to express cytokeratins may therefore be expla- There is a precedent for this finding of an epithelial component in a tumour previously thought to be mesenchymal in origin. Recently, both mesotheliomas and synovial sarcomas, tumour types also regarded as mesenchymal but with epithelial features have been shown to express vimentin, EMA, and cytokeratins.20 -22 A common feature of synovium, mesothelium, and meningeal arachnoid cells is that, although believed to be mesenchymal, they line body cavities and perform some functions equivalent to conventional epithelium. It is therefore not surprising that they, and tumours arising from them, should express markers of "epithelial" differentiation despite their mesenchymal origin. This mechanism seems a more likely explanation than the mixed tumour theory.
Although meningiomas are usually a straightforward diagnosis despite their wide range of morphological appearances, they may occasionally be difficult to distinguish from other intracranial tumours including metastases. Recent studies have suggested that metastatic carcinomas can be distinguished by their positivity for epithelial markers and lack of neural markers. 
